Tag: <span>immune response .</span>

Home / immune response .
Study finds drug beneficial for shrinking mesothelioma tumors
Post

Study finds drug beneficial for shrinking mesothelioma tumors

by National Cancer Institute A drug that is designed to boost the immune system against mesothelioma, when combined with immunotherapy, was found to be beneficial in a small study involving ten patients. The results, which appeared July 1, 2020, in Science Translational Medicine, suggest that the drug LMB-100 could prolong the life of some patients...

B-cell protectors
Post

B-cell protectors

MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE IN THE HELMHOLTZ ASSOCIATION THE PROTEIN PDAP1 (RED) IS LOCATED IN THE CYTOPLASM OF B CELLS. view more CREDIT: DI VIRGILIO, MDC Whenever a germ gets into the human body, the immune system usually responds immediately to fight off the enemy attacker. One of our defense system’s most important...

Post

New vaccination strategy targets toxic molecules released by all Staphylococcal bacteria

Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments. The new vaccination strategy, developed by researchers at NYU Grossman School of Medicine, targets toxic molecules released by all Staphylococcal bacteria, called leukocidins, rather than directly...

NIH investigators hope CD47 study leads to broad-spectrum infectious diseases immunotherapy
Post

NIH investigators hope CD47 study leads to broad-spectrum infectious diseases immunotherapy

National Institutes of Health investigators and colleagues have discovered that when the immune system first responds to infectious agents such as viruses or bacteria, a natural brake on the response prevents overactivation. Their new study in mBio describes this brake and the way pathogens such as SARS-CoV-2, the virus that causes COVID-19, turn it on....

Post

Case series: Teriflunomide therapy in COVID-19 patients with MS

During the COVID-19 pandemic, patients with multiple sclerosis (MS) and their clinicians have had questions and concerns about whether immunotherapies for MS could influence risk for infection or lead to an unfavorable outcome. In the Journal of Neurology, Rohit Bakshi, MD, a senior neurologist at Brigham and Women’s Hospital, and international co-authors present the cases...

Are Patients Dying ‘From’ COVID or ‘With’ COVID?
Post

Are Patients Dying ‘From’ COVID or ‘With’ COVID?

George D. Lundberg, MD DISCLOSURES June 05, 2020 Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Death is usually fairly easy to diagnose; cause of death, not so much. In fact, death certificates in the United States and around the world are notoriously wrong. How does this happen? Death certificates are...

Post

Birmingham scientists ‘re-train’ immune system to prevent attack of healthy cells

The body’s immune system can be re-wired to prevent it from recognising its own proteins which, when attacked by the body, can cause autoimmune diseases like multiple sclerosis, a significant new study by UK scientists has found. Autoimmune diseases are caused when the immune system loses its normal focus on fighting infections or disease within...

First Human Trial Of Possible COVID-19 Vaccine Triggers Rapid Immune Response, Few Side-Effects
Post

First Human Trial Of Possible COVID-19 Vaccine Triggers Rapid Immune Response, Few Side-Effects

by Chris Melore WUHAN, China — As the worldwide number of COVID-19 cases reaches five million, the search for a vaccine has taken an important step forward. Researchers say the first human trial of a possible vaccine has been found to be safe and may effectively fight the virus. Scientists in China say 108 healthy adults were given...